A carregar...
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
Nonalcoholic fatty liver disease (NAFLD) is a global epidemic that is likely to become the most common cause of chronic liver disease in the next decade, worldwide. Though numerous drugs have been evaluated in clinical trials, most of them have returned inconclusive results and shown poorly-tolerate...
Na minha lista:
| Publicado no: | J Clin Transl Hepatol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
XIA & HE Publishing Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7868704/ https://ncbi.nlm.nih.gov/pubmed/33604254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2020.00055 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|